← Back to Search

Intraocular Lens

Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens

N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 120 to day 180 after second eye implantation
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new type of lens called the enVista trifocal intraocular lens for people over 40 with cataracts. The lens is designed to help them see better at all distances after surgery.

Eligible Conditions
  • Cataract
  • Pseudoaphakia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 120 to day 180 after second eye implantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 120 to day 180 after second eye implantation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Photopic monocular best-corrected distance visual acuity (BCDVA)
Photopic monocular distance-corrected intermediate visual acuity (DCIVA)
Photopic monocular distance-corrected near visual acuity (DCNVA)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: enVista MX60EFExperimental Treatment1 Intervention
enVista MX60EF (trifocal) multifocal IOL (MIOL)
Group II: enVista MX60EActive Control1 Intervention
enVista MX60E monofocal IOL
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
enVista MX60EF
2018
N/A
~510

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
257 Previous Clinical Trials
57,729 Total Patients Enrolled
49 Trials studying Cataract
16,032 Patients Enrolled for Cataract
Anya LoncaricStudy DirectorBausch health companies
39 Previous Clinical Trials
20,162 Total Patients Enrolled
5 Trials studying Cataract
1,751 Patients Enrolled for Cataract
~67 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top